Phencyclidine (PCP) and some of its pharmacological congeners inhibit the signal transduction at specific excitatory amino acid receptors of cerebellar granule cells in primary cultures. These drugs do not bind to the transmitter recognition sites, and affinity of this specific binding site is increased by the These drugs need the presence of the transmitter to act and they cannot be termed inverse agonists because they are devoid of activity in the absence of the transmitter; moreover, they do not bind to the transmitter recognition site nor do they prevent the transmitter binding to its recognition sites.
(Gpl) but not that mediated by Mg2+-insensitive glutamate receptors (Gp2). In addition, PCP inhibits Ca2+ influx and cGMP formation mediated by the activation of Mg2+-sensitive glutamate receptors (Gc1) but not that mediated by Mg2+-insensitive glutamate receptors (GC2). In this cell culture the activation of phosphatidylinositol phosphate hydrolysis by muscarinic receptor agonists is not affected by PCP. Since PCP inhibits noncompetitively Gpj and Gc1 signal transduction it may act as a negative allosteric modulator of signal transduction at both receptors. The pharmacological profile of PCP and its congeners delimits a class of drugs modulating allosterically the action of the primary transmitter at Gpj and Gc1 receptors.
These drugs need the presence of the transmitter to act and they cannot be termed inverse agonists because they are devoid of activity in the absence of the transmitter; moreover, they do not bind to the transmitter recognition site nor do they prevent the transmitter binding to its recognition sites. In primary cultures of cerebellar granule cells, excitatory amino acid recognition sites are coupled to specific signaltransducing mechanisms. These mechanisms include (i) the hydrolysis of membrane phosphatidylinositol phosphates (1, 2) and (ii) the activation of receptor-operated Ca2+ influx, leading to an enhanced intracellular Ca2+ content (3, 4) and a consequent increase in cGMP formation (5) . Hence, we have proposed a classification of excitatory amino acid receptors that takes into account the different modalities of receptor operation. We do not know yet whether recognition sites for transmitters are located in the signal-transducing molecule, but at least in the case of those recognition sites coupled to the transducer by a GTP-binding protein, it appears that the transmitter recognition site is located in a molecule different from that operating the signal transduction. Our classification distinguishes between excitatory amino acid recognition sites coupled with phosphatidylinositol phosphate hydrolysis (Gp) and those coupled with the activation of Ca2+ influx (Gc) (6 rats (Zivic-Miller, Pittsburgh) as described (1), according to the method of Gallo et al. (7) . These cultures contain >90% ofgranule neurones, about 5% of GABA-ergic interneurones, and a small amount of astrocytes, oligodendrocytes, and endothelial cells as contaminants (1, 8) . Cultures at 7-9 days in vitro were used in all of the experiments.
Measurement of PCP Binding. Granule cells were harvested, homogenized, and centrifuged twice for 20 min at 45,000 x g in 10 mM Tris-HCl buffer (pH 7. [3H]inositol (9) . Intracellular cGMP levels were estimated by RIA, as described (5 over, PCP interacts with specific membrane recognition sites (24) (25) (26) (27) ; though they are distinct from the excitatory amino acid recognition sites, the affinity of PCP binding sites is increased when glutamate receptors bind an agonist. These data taken together indicate that PCP is a negative allosteric modulation of GP, and Gc1 receptors. Cerebellar granule cells in culture express a single population of specific and saturable PCP binding sites with an affinity oscillating according to the degree ofglutamate receptor occupancy (Kd ranging from 170 to 290 nM). This affinity but not the Bm,, is reduced to 540 nM in the presence of the glutamate antagonist APV (Fig. 2) . These results suggest that in the supramolecular structure of GP1 and Gc1 receptors, the recognition sites for excitatory amino acids and PCP interact in such a way that the binding of glutamate to its site increases the affinity of PCP binding site for its specific ligands.
The molecular mechanism whereby PCP and its pharmacological congeners inhibit signal transduction at GP1 and Gc1 (29, 30) , the domain for the allosteric modulation of Gc1 and Gp1 receptors cannot be defined with precision at this time; however, the discovery of an endogenous ligand for PCP recognition sites (31) indicates that these sites may have a physiological role in modulating excitatory amino acid signal transduction at Gp1 and Gc1 receptors. Neurobiology: Wroblewski et al.
